Personal information

Countries

United States

Activities

Collapse all

Employment (3)

TSC Alliance: Silver Spring, MD, US

2019-04-01 to present (Science/Medical)
Employment
Source: Self-asserted source
Zoë Fuchs

George Washington University Medical Faculty Associates: Washington, DC, US

2018-04-01 to 2019-03-31 | Medical Scribe (Oncology, Urology, Radiation Oncology)
Employment
Source: Self-asserted source
Zoë Fuchs

University of California Los Angeles: Los Angeles, CA, US

2015-09-01 to 2017-05-31 | Staff Research Assistant (Jonsson Comprehensive Cancer Center: Translational Oncology Research Laboratory)
Employment
Source: Self-asserted source
Zoë Fuchs

Education and qualifications (1)

University of California Santa Barbara: Santa Barbara, CA, US

2011-09-01 to 2015-06-01 | BS Chemical Engineering
Education
Source: Self-asserted source
Zoë Fuchs

Works (6)

The role of the TSC Alliance in advancing therapy development: a patient organization perspective

Therapeutic Advances in Rare Disease
2024-01 | Journal article
DOI: 10.1177/26330040241265411
Contributors: Steven L. Roberds; Zoë Fuchs; Elizabeth M. Cassidy; Samantha Metzger; Ayat Abi; Ashley J. Pounders; Dean J. Aguiar
Source: check_circle
Crossref

Strategies for inclusive grantmaking

Nature Medicine
2022-04 | Journal article
DOI: 10.1038/s41591-022-01757-8
Contributors: Maryrose Franko; Sindy Escobar-Alvarez; Zoë Fuchs; Kimberly Lezak; Lindsay Redman Rivera; Miquella C. Rose; Kristen L. Mueller
Source: check_circle
Crossref

Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations

Pediatric Neurology
2021-07 | Journal article
DOI: 10.1016/j.pediatrneurol.2021.07.011
Part of ISSN: 0887-8994
Source: Self-asserted source
Zoë Fuchs

Activity of the Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Copanlisib, As a Single Agent and in Combination with Carfilzomib in Multiple Myeloma

Blood
2016-12 | Journal article
DOI: 10.1182/blood.V128.22.5665.5665
Part of ISSN: 0006-4971
Source: Self-asserted source
Zoë Fuchs

DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.

Journal of controlled release : official journal of the Controlled Release Society
2016-03-24 | Journal article
DOI: 10.1016/j.jconrel.2016.03.027
PMID: 27034194
PMC: PMC5289372
Source: Self-asserted source
Zoë Fuchs

Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid.

Journal of controlled release : official journal of the Controlled Release Society
2015-04-25 | Journal article
DOI: 10.1016/j.jconrel.2015.04.031
PMID: 25921087
PMC: PMC4470752
Source: Self-asserted source
Zoë Fuchs
How many people are using ORCID?